Primary Squamous Cell Carcinoma of the Liver Initially Presenting with Pseudoachalasia by Choi, Mun Ki et al.
CASE REPORT 
Gut and Liver, Vol. 6, No. 2, April 2012, pp. 275-279
Primary Squamous Cell Carcinoma of the Liver Initially Presenting with 
Pseudoachalasia
Mun Ki Choi*, Gwang Ha Kim*, Geun Am Song*, Hyung Seok Nam*, Yang Seon Yi*, Kang Hee Ahn*, Suk Kim
†, Joo Yeun 
Kim
‡, and Do Youn Park
‡
Departments of *Internal Medicine, 
†Radiology, and 
‡Pathology, Pusan National University School of Medicine, Busan, Korea
Pseudoachalasia secondary to primary squamous cell car-
cinoma (SCC) of the liver is extremely rare and has not been 
reported until now. Here, we report a unique case of primary 
SCC of the liver initially presenting with progressive dysphagia 
along with short periods of signiﬁ  cant weight loss. A 58-year-
old man initially presented with progressive dysphagia along 
with significant weight loss over brief periods of time. The 
radiographic and manometric ﬁ  ndings were consistent with 
achalasia. Subsequent esophagogastroduodenoscopy re-
vealed a moderately dilated esophagus without evidence of 
neoplasm or organic obstruction. However, firm resistance 
was encountered while traversing the esophagogastric junc-
tion (EGJ), although no mucosal lesion was identiﬁ  ed. Due to 
the clinical suspicion of the presence of a malignant tumor, 
endoscopic ultrasonography (EUS) and computed tomogra-
phy scans of the chest and abdomen were obtained. A huge 
hepatic mass with irregular margins extending to the EGJ was 
found. EUS-guided fine-needle aspiration was performed, 
and the mass was diagnosed as a primary SCC of the liver by 
immunohistochemical staining. (Gut Liver 2012;6:275-279)
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INTRODUCTION
Pseudoachalasia secondary to primary squamous cell carci-
noma (SCC) of the liver is extremely rare
1-3 and has not been 
reported until now. In this report, we describe a unique case of 
primary SCC of the liver initially presenting with progressive 
dysphagia along with short periods of significant weight loss. 
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Esophageal manometric and radiographic findings showed fea-
tures of achalasia.
CASE REPORT
A 58-year-old man was referred to our hospital for further 
evaluation and management of progressive dysphasia for 3 
months. He complained of postprandial vomiting and weight 
loss of 20 kg during the last 3 months. The patient’s past medi-
cal history was unremarkable, and physical examination re-
vealed an adequate state of health. Laboratory studies, including 
tumor markers, were normal except for increased white blood 
cell count of 13,510 cells/μL (normal 4,000 to 11,000 cells/μL), 
elevated alkaline phosphatase of 562 U/L (95 to 280 U/L), and a 
slightly high C-reactive protein of 6.16 mg/dL (0 to 0.5 mg/dL).
A barium swallow study revealed a smooth narrowing of the 
distal esophagus with a marked dilation of the proximal seg-
ment (Fig. 1). Esophageal manometry demonstrated a lack of 
primary peristalsis, increased resting lower esophageal sphincter 
(LES) pressure (89.4 mm Hg) and incomplete relaxation of the 
LES during wet swallows (53% relaxation), suggesting a diag-
nosis of achalasia (Fig. 2). Subsequent esophagogastroduode-
noscopy (EGD) showed a moderately dilated esophagus without 
evidence of neoplasm or organic obstruction (Fig. 3A and B). 
However, firm resistance was encountered while traversing the 
esophagogastric junction (EGJ), although no mucosal lesion was 
identified. With clinical suspicion of the presence of a malignant 
tumor, we proceeded to perform endoscopic ultrasonography 
(EUS) and contrast-enhanced computed tomography (CT) scans 
of the chest and abdomen. 
EUS revealed an approximately 7 cm hypoechoic, heteroge-276  Gut and Liver, Vol. 6, No. 2, April 2012
neous mass with irregular margins around the EGJ (Fig. 3C). In 
addition, the main mass was mainly located outside the esopha-
gus and it invaded into the muscle layer, not to submucosal 
layer. This suggests that the mass was originated outside the 
esophagus, not from the esophagus. Thoraco-abdominal CT scans 
showed a massive tumor at the left lobe of the liver in size to 9 
cm in largest diameter, extending to the EGJ, but no features of 
underlying liver cirrhosis or pulmonary lesions (Fig. 4A and B). 
US-guided biopsies were performed of the mass at the left lobe 
of the liver, but the tissues obtained were deemed unsatisfactory 
for diagnosis due to necrosis and limited sampling of viable 
tumor cells. Therefore, we conducted a EUS-guided fine needle 
aspiration (FNA) biopsy on the peripheral non-necrotic area. 
Six needle passes were made with a 22-gauge needle (Echotip; 
Wilson-Cook, Winston-Salem, NC, USA), and the histopatho-
logical diagnosis was poorly differentiated SCC (Fig. 5A). Immu-
nohiostochemical staining was positive for p63 and cytokeratin 
(CK) 19, but negative for thyroid transcription factor-1 (TTF-1), 
indicating primary SCC of the liver (Fig. 5B-D). We performed 
a systemic evaluation to identify the primary tumor origin with 
an ENT survey and positron emission tomography-CT (PET-CT) 
scans (Fig. 4C), but did not detect any other abnormalities. The 
patient was diagnosed as pseudoachalasia secondary to primary 
SCC of the liver.
We recommended concurrent platinum-based chemotherapy 
and radiotherapy due to the inoperable state of the tumor, but 
the patient refused all treatments, including palliation with 
esophageal stents and died four months later.
DISCUSSION
Primary SCC of the liver is a rare malignant neoplasm, and 
right upper quadrant abdominal pain is a prominent symptom 
in previously reported cases.
1-3 In contrast, our patient presented 
Fig. 1. Barium esophagography displays a markedly dilated esopha-
gus tapering to a smoothly narrowed gastroesophageal junction.
Fig. 2. The esophageal manometry findings are consistent with acha-
lasia: a lack of primary peristalsis, increased resting lower esophageal 
sphincter (LES) pressure (89.4 mm Hg) and incomplete relaxation of 
the LES during wet swallows (53% relaxation).
Fig. 3. (A) Esophagogastroduodenoscopy reveals a moderately dilated esophagus and tight esophagogastric junction (EGJ). (B) The U-turn view 
reveals no evidence of neoplasm at the cardia. (C) Endoscopic ultrasonography displays a large hypoechoic, inhomogeneous mass with irregular 
margins around the EGJ.Choi MK, et al: Primary Squamous Cell Carcinoma of Liver Presenting Pseudoachalasia  277
Fig. 4. (A, B) Abdominal computed 
tomography (CT) scans demon-
strate a large tumor adjacent to the 
esophagogastric junction at the left 
lobe of the liver. (C) Positron emis-
sion tomography-CT scans display 
a mass at the left lobe of the liver 
with peripheral rim-shaped fluoro 
deoxyglucose uptake. 
Fig. 5. (A) Clusters of atypical epithelial cells in the necrotic background, which are consistent with poorly differentiated squamous cell carcinoma 
(H&E stain, ×400). (B) Positive p63 staining (×400). (C) Positive CK19 staining (×200). (D) Negative TTF-1 staining (×200).278  Gut and Liver, Vol. 6, No. 2, April 2012
with progressive dysphagia and postprandial vomiting, as well 
as manometric and radiographic features of achalasia. To our 
knowledge, this case of primary SCC of the liver initially pre-
senting as pseudoachalasia is the first to be described in the 
literature.
Malignant pseudoachalasia accounts for 4% of all cases of 
achalasia.
4 Whereas adenocarcinoma of the gastric cardia ac-
counts for most cases, other malignant tumors such as lym-
phoma, mesothelioma, hepatoma, cholangiocarcinoma, renal 
cell carcinoma and carcinoma of the esophagus, lung, pancreas, 
prostate, breast, colon, and duodenum have been reported.
5 Such 
malignant tumors usually produce achalasia as the result of one 
of three mechanisms.
6,7 First, the tumor mass may encircle or 
compress the distal esophagus, thereby producing a constricting 
segment. Second, malignant cells may infiltrate the esophageal 
myenteric plexus and impair postganglionic innervation of the 
LES. Third, paraneoplastic visceral neuropathy of the myenteric 
plexus without neoplastic infiltration of the EGJ may produce 
clinical features of achalasia. The pseudoachalasia observed 
in this case was likely a result of tumor bulk compressing the 
distal esophagus with neoplastic infiltration of the esophageal 
myenteric plexus.
Pseudoachalasia associated with malignancy has clinical, 
radiographic, and manometric features that are often indistin-
guishable from primary achalasia. Moreover, due to the rarity 
of the disease, many patients with pseudoachalasia are initially 
diagnosed as primary achalasia. Unfortunately, if not promptly 
recognized, pseudoachalasia may be inappropriately treated with 
pneumatic dilation of the LES, which is both ineffective and 
dangerous,
8 and may delay proper treatment of the underlying 
malignancy. Thus, all patients with suspected achalasia should 
undergo EGD to exclude a diagnosis of tumor at the cardia or 
EGJ. Although submucosal or extramural tumors will inevitably 
be missed by normal endoscopic examination, encountering 
excessive resistance while traversing the EGJ should strongly 
suggest a diagnosis of pseudoachalasia. In the present case, this 
fact was a significant key facilitating an accurate diagnosis.
In addition, certain historical features can help raise suspicion 
of a malignant tumor. A short duration of symptoms (less than 
1 year), presentation later in life (more than 55 years of age), 
and significant weight loss (more than 15 lbs) are more typical 
of malignancy than of primary achalasia.
9 All of these criteria 
were met in our patient. However, these criteria have poor pre-
dictive value, so early exploratory surgery is not recommended 
without radiologic or endoscopic evidence of tumors.
10
Pseudoachalasia may be better confirmed by EUS, which pro-
vides more definitive imaging of the extrinsic lesion and enables 
identification of subepithelial tumor infiltration through biopsy 
or cytologic brushing.
11 CT scans and magnetic resonance imag-
ing may also be useful for distinguishing the two disorders. CT 
findings that might favor a diagnosis of pseudoachalasia versus 
primary achalasia include a more marked or asymmetric thick-
ening of the esophagus and the presence of a mass.
12
Our patient underwent further evaluation with EUS and CT 
scans, revealing a mass at the left lobe of the liver. Unexpect-
edly, EUS-FNA biopsy of the mass was positive for SCC. The 
positive staining of CK19 confirmed the bile ductular ontogeny 
of the neoplastic cells. Because TTF-1, an indicator of lung or 
thyroid origin, was negative, we were able to rule out metastasis 
of lung or thyroid cancer to the liver. Endoscopy, ENT examina-
tion, thoraco-abdominal CT scans, and PET-CT scans supported 
that the liver was the primary origin of the tumor.
In summary, it is important to differentiate primary achalasia 
from secondary achalasia. Diagnosis requires clinical suspicion 
in addition to routine radiographs, esophageal manometry and 
endoscopy. These should be followed by EUS or CT scans. Pri-
mary SCC of the liver is a very rare disease, and requires careful 
systemic evaluation and immunohistochemical examination. 
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